Daan van de Kerkhof

1.1k total citations
55 papers, 805 citations indexed

About

Daan van de Kerkhof is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Physiology. According to data from OpenAlex, Daan van de Kerkhof has authored 55 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 15 papers in Hematology and 9 papers in Physiology. Recurrent topics in Daan van de Kerkhof's work include Atrial Fibrillation Management and Outcomes (14 papers), Blood groups and transfusion (10 papers) and Hemoglobinopathies and Related Disorders (7 papers). Daan van de Kerkhof is often cited by papers focused on Atrial Fibrillation Management and Outcomes (14 papers), Blood groups and transfusion (10 papers) and Hemoglobinopathies and Related Disorders (7 papers). Daan van de Kerkhof collaborates with scholars based in Netherlands, Denmark and Belgium. Daan van de Kerkhof's co-authors include Volkher Scharnhorst, Luc Brunsveld, Joost L. J. van Dongen, Mark W.M. Schellings, Francisca Hudig, Fedde van der Graaf, Rutger A. Middelburg, Karen M. K. de Vooght, Jaap Jan Zwaginga and Dorothea Evers and has published in prestigious journals such as JAMA, Blood and Analytical Chemistry.

In The Last Decade

Daan van de Kerkhof

50 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daan van de Kerkhof Netherlands 16 249 225 153 138 102 55 805
Anton P. van Zanten Netherlands 19 82 0.3× 176 0.8× 58 0.4× 74 0.5× 170 1.7× 43 896
Michael Desborough United Kingdom 20 171 0.7× 420 1.9× 38 0.2× 122 0.9× 180 1.8× 68 1.4k
Bruce A. Schwartz United States 18 454 1.8× 621 2.8× 153 1.0× 481 3.5× 101 1.0× 33 1.7k
Y Gourmelin France 7 421 1.7× 173 0.8× 63 0.4× 371 2.7× 25 0.2× 17 673
François Depasse France 16 562 2.3× 453 2.0× 44 0.3× 541 3.9× 57 0.6× 40 1.1k
Marilyn F.M. Johnston United States 16 69 0.3× 279 1.2× 39 0.3× 42 0.3× 69 0.7× 31 864
Silvia Villa Italy 12 174 0.7× 99 0.4× 27 0.2× 50 0.4× 34 0.3× 26 546
Carlo Giammarresi Italy 11 318 1.3× 68 0.3× 36 0.2× 64 0.5× 9 0.1× 26 661
Maria Kotsopoulou Greece 13 137 0.6× 128 0.6× 33 0.2× 13 0.1× 51 0.5× 27 516
JA Ware United States 8 91 0.4× 151 0.7× 23 0.2× 33 0.2× 26 0.3× 13 465

Countries citing papers authored by Daan van de Kerkhof

Since Specialization
Citations

This map shows the geographic impact of Daan van de Kerkhof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daan van de Kerkhof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daan van de Kerkhof more than expected).

Fields of papers citing papers by Daan van de Kerkhof

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daan van de Kerkhof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daan van de Kerkhof. The network helps show where Daan van de Kerkhof may publish in the future.

Co-authorship network of co-authors of Daan van de Kerkhof

This figure shows the co-authorship network connecting the top 25 collaborators of Daan van de Kerkhof. A scholar is included among the top collaborators of Daan van de Kerkhof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daan van de Kerkhof. Daan van de Kerkhof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peri, Elisabetta, et al.. (2025). A novel kinetic model estimating the urea concentration in plasma during non-invasive sweat-based monitoring in hemodialysis. Frontiers in Physiology. 16. 1547117–1547117. 1 indexed citations
2.
Streng, Alexander S., Maarten A.C. Broeren, Maarten J. Deenen, et al.. (2024). Partial protein binding of uracil and thymine affects accurate dihydropyrimidine dehydrogenase (DPD) phenotyping. Journal of Pharmaceutical and Biomedical Analysis. 249. 116381–116381.
3.
Haas, Masja de, Karen M. K. de Vooght, Daan van de Kerkhof, et al.. (2024). Challenging the dogma: Red blood cell‐directed autoimmunity as risk factor for red blood cell alloimmunisation after blood transfusion. British Journal of Haematology. 204(5). 2103–2111.
4.
Broeren, Maarten A.C., et al.. (2024). Immunoaffinity Intact Top-Down Mass Spectrometry for Quantification of Neuron-Specific Enolase Gamma, a Low-Abundance Protein Biomarker. Analytical Chemistry. 97(1). 516–525. 2 indexed citations
5.
Broeren, Maarten A.C., et al.. (2024). Immunoaffinity Intact-Mass Spectrometry for the Detection of Endogenous Concentrations of the Acetylated Protein Tumor Biomarker Neuron Specific Enolase. Journal of Proteome Research. 23(8). 3726–3730. 2 indexed citations
6.
Konings, Constantijn, et al.. (2024). A novel LC-MS/MS assay for low concentrations of creatinine in sweat and saliva to validate biosensors for continuous monitoring of renal function. Journal of Chromatography B. 1252. 124444–124444. 3 indexed citations
7.
Konings, Constantijn, et al.. (2024). The correlation of urea and creatinine concentrations in sweat and saliva with plasma during hemodialysis: an observational cohort study. Clinical Chemistry and Laboratory Medicine (CCLM). 62(6). 1118–1125. 9 indexed citations
8.
Belderbos, Huub, Gerben Stege, Luc Brunsveld, et al.. (2024). Strengths and challenges in current lung cancer care: Timeliness and diagnostic procedures in six Dutch hospitals. Lung Cancer. 189. 107477–107477. 2 indexed citations
9.
Péquériaux, Nathalie C. V., et al.. (2023). Effect of conventional hemodialysis on the apixaban plasma concentration. Hemodialysis International. 28(1). 72–76.
10.
Valk, Sarah J, Camila Caram‐Deelder, Dorothea Evers, et al.. (2023). Donor pregnancies and transfusion recipient mortality: A role for red blood cell storage?. Vox Sanguinis. 119(1). 43–52. 1 indexed citations
11.
Verboogen, Daniëlle R. J., Bernd Granzen, Daan van de Kerkhof, et al.. (2023). Heterophilic antibodies leading to falsely positive D-dimer concentration in an adolescent. Research and Practice in Thrombosis and Haemostasis. 7(1). 100017–100017. 2 indexed citations
12.
Koldewijn, Evert L., et al.. (2020). Novel urinary biomarkers ADXBLADDER and bladder EpiCheck for diagnostics of bladder cancer: A review. Urologic Oncology Seminars and Original Investigations. 39(3). 161–170. 23 indexed citations
13.
Evers, Dorothea, Rutger A. Middelburg, Karen M. K. de Vooght, et al.. (2020). Association between renal failure and red blood cell alloimmunization among newly transfused patients. Transfusion. 61(1). 35–41. 6 indexed citations
14.
Scharnhorst, Volkher, et al.. (2018). A value proposition for trough level-based anti-TNFα drug dosing. Clinica Chimica Acta. 489. 89–95. 2 indexed citations
15.
Boonen, Kristel J.M., et al.. (2017). Real life dabigatran and metabolite concentrations, focused on inter-patient variability and assay differences in patients with atrial fibrillation. Clinical Chemistry and Laboratory Medicine (CCLM). 55(12). 2002–2009. 8 indexed citations
16.
Evers, Dorothea, Rutger A. Middelburg, Masja de Haas, et al.. (2016). Red-blood-cell alloimmunisation in relation to antigens' exposure and their immunogenicity: a cohort study. The Lancet Haematology. 3(6). e284–e292. 80 indexed citations
17.
Kerkhof, Daan van de, et al.. (2016). Left atrial thrombus under dabigatran in a patient with nonvalvular atrial fibrillation.. PubMed. 74(7). 313–5. 4 indexed citations
18.
Curvers, Joyce, et al.. (2012). Measuring Direct Thrombin Inhibitors With Routine and Dedicated Coagulation Assays. American Journal of Clinical Pathology. 138(4). 551–558. 61 indexed citations
19.
Boonen, Kristel J.M., et al.. (2011). Trueness in the measurement of haemoglobin: consensus or reference method?. Clinical Chemistry and Laboratory Medicine (CCLM). 50(3). 511–4. 2 indexed citations
20.
Kerkhof, Daan van de, Douwe de Boer, Roel H. Fokkens, et al.. (2002). Artifact formation due to ethyl thio-incorporation into silylated steroid structures as determined in doping analysis. Journal of Chromatography A. 954(1-2). 199–206. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anton P. van Zanten Breakdown of academic impact, for papers by Michael Desborough Breakdown of academic impact, for papers by Bruce A. Schwartz Breakdown of academic impact, for papers by Y Gourmelin Breakdown of academic impact, for papers by François Depasse Breakdown of academic impact, for papers by Marilyn F.M. Johnston Breakdown of academic impact, for papers by Silvia Villa Breakdown of academic impact, for papers by Carlo Giammarresi Breakdown of academic impact, for papers by Maria Kotsopoulou Breakdown of academic impact, for papers by JA Ware
Rankless by CCL
2026